Key result
Novel valve uptake index >0.45 diagnoses prosthetic valve endocarditis with ~87% accuracy.
Why the study?
The fluorodeoxyglucose uptake pattern on PET/CTA for diagnosing prosthetic valve endocarditis can be visually unclear and susceptible to subjectivity. This study aimed to validate a new parameter, the valve uptake index, to provide a more objective indication of metabolic activity distribution and to evaluate its addition to traditional imaging criteria.
Does the valve uptake index (VUI) on [18F]FDG PET/CTA improve the objective assessment and diagnostic accuracy for prosthetic valve endocarditis in patients admitted with suspected prosthetic valve infection?
Cohort (n=122)
No
Does the valve uptake index (VUI) on [18F]FDG PET/CTA improve the objective assessment and diagnostic accuracy for prosthetic valve endocarditis in patients admitted with suspected prosthetic valve infection?
The valve uptake index (VUI > 0.45) provides an objective, reproducible metric of FDG distribution homogeneity on cardiac PET/CTA that achieves 86.7% diagnostic accuracy for prosthetic valve endocarditis and improves diagnostic performance when combined with traditional visual and anatomical criteria.
Answers are grounded in this paper and cite their sources.
VUI >0.45 may aid objective PVE assessment on PET/CTA; extends quantitative criteria but leaves open prospective validation before adoption.
AIMS: Diagnosis of prosthetic valve endocarditis (PVE) by positron emission computed tomography angiography (PET/CTA) is based on visual and quantitative morpho-metabolic features. However, the fluorodeoxyglucose (FDG) uptake pattern can be sometimes visually unclear and susceptible to subjectivity. This study aimed to validate a new parameter, the valve uptake index [VUI, maximum standardized uptake value (SUVmax)-mean standardized uptake value (SUVmean)/SUVmax], designed to provide a more objective indication of the distribution of metabolic activity. Secondly, to re-evaluate the utility of traditionally used PVE imaging criteria and determine the potential value of adding the VUI in the diagnostic algorithm of PVE. METHODS AND RESULTS: Retrospective analysis of 122 patients (135 prosthetic valves) admitted for suspicion of endocarditis, with a conclusive diagnosis of definite (N = 57) or rejected (N = 65) PVE, and who had undergone a cardiac PET/CTA scan as part of the diagnostic evaluation. We measured the VUI and recorded the SUVmax, SUVratio, uptake pattern, and the presence of endocarditis-related anatomic lesions. The VUI, SUVmax, and SUVratio values were 0.54 ± 0.1 vs. 0.36 ± 0.08, 7.68 ± 3.07 vs. 3.72 ± 1.11, and 4.28 ± 1.93 vs. 2.16 ± 0.95 in the 'definite' PVE group vs. the 'rejected' group, respectively (mean ± SD; P < 0.001). A cut-off value of VUI > 0.45 showed a sensitivity, specificity, and diagnostic accuracy for PVE of 85%, 88%, and 86.7% and increased diagnostic ability for confirming endocarditis when combined with the standard diagnostic criteria. CONCLUSIONS: The VUI demonstrated good diagnostic accuracy for PVE, even increasing the diagnostic power of the traditionally used morphometabolic parameters, which also confirmed their own diagnostic performance. More research is needed to assess whether the integration of the VUI into the PVE diagnostic algorithm may clarify doubtful cases and thus improve the diagnostic yield of PET/CTA.
No takes yet. Share an insight, caveat, or question.
Roque et al. (2021) conducted a cohort in Suspected prosthetic valve endocarditis (PVE) (n=122). Valve uptake index (VUI) on cardiac [18F]FDG PET/CTA vs. Rejected prosthetic valve endocarditis (or standard morpho-metabolic PET/CTA imaging criteria) was evaluated on Mean Valve Uptake Index (VUI) and diagnostic accuracy for definite vs. rejected prosthetic valve endocarditis (p=<0.001). The valve uptake index (VUI) was higher in definite vs. rejected PVE, with VUI >0.45 showing 85% sensitivity, 88% specificity, and 86.7% accuracy.
Synapse has enriched 10 related papers. Consider them for comparative context: